Advertisement
Advertisement
U.S. Markets open in 3 hrs 37 mins
Advertisement
Advertisement
Advertisement
Advertisement

ICBCCS SSE STAR 50 ETF (588050.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
0.9720-0.0220 (-2.21%)
At close: 02:59PM CST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.9940
Open0.9900
Bid0.9720 x N/A
Ask0.9730 x N/A
Day's Range0.9710 - 0.9940
52 Week Range0.8810 - 1.5250
Volume155,138,901
Avg. Volume178,264,941
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    PTSD, Depression and Addiction Soar Amid Skyrocketing Cases of Omicron

    As Americans brace themselves for year three of pandemic life, their mental health hits an all-time low, according to the Mental Health Index: U.S. Worker Edition. Most notably, PTSD, depression and addiction soar amid skyrocketing cases of Omicron. An alarming 1 in 4 American workers screened positive for post-traumatic stress disorder (PTSD) – up 54% in the past three months and up 136% when compared to pre-pandemic. Depression is surging – up 87% since fall (63% higher than before COVID19).

  • PR Newswire

    Kerna Health Signs Deal with Total Brain; Will Integrate Total Brain Platform into Existing Behavioral Health Technologies

    Total Brain, a mental health and brain performance monitoring and support platform, today announced that the company has signed a deal with Kerna Health, a leader in digital connected care. As part of the newly minted agreement, Kerna will integrate the Total Brain digital neurotech platform into the company's Behavioral Health Integration support solution. Under the terms of the non-exclusive deal, and as the partnership scales over the upcoming 12-18 months, Total Brain's assessment and self-c

  • PR Newswire

    Total Brain Licenses iSPOT-D for Depression Research

    Total Brain today announced that the company will license its International Study to Predict Optimized Treatment for Depression (iSPOT-D) research data to Janssen Research & Development, LLC. The company will use Total Brain's iSPOT-D data to support clinical studies and precision drug development efforts to treat depression.

Advertisement
Advertisement